Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.75
Bid: 32.50
Ask: 33.00
Change: -0.25 (-0.76%)
Spread: 0.50 (1.538%)
Open: 32.50
High: 32.75
Low: 32.50
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Re-Admission and First Day of Dealings

23 Mar 2017 17:00

RNS Number : 3903A
Duke Royalty Limited
23 March 2017
 

 

Duke Royalty Limited

("Duke Royalty" or the "Company")

 

Re-Admission and First Day of Dealings

 

St. Peter Port, Guernsey - March 23, 2017 - Duke Royalty Limited, a public diversified royalty company (AIM: DUKE), is pleased to announce the commencement of dealings earlier today in its ordinary shares having successfully raised £15 million before expenses (the "Fundraising"), as announced on 17 March 2017.

The Company's Nominated Adviser, Grant Thornton UK LLP, advised the Company in relation to its re-admission to AIM and Fundraising and Cantor Fitzgerald Europe and Mirabaud Securities LLP acted as Joint Brokers to the Company.

 

SUMMARY

· Pursuant to the Fundraising, a total of 37,500,000 New Shares have been successfully placed or subscribed for in the Company at a price of 40 pence per share (the "Issue Price"), with new and existing institutional investors, as well as certain Directors.

· Gross proceeds of £15.0 million (net proceeds £13.8 million after expenses) were raised pursuant to the Fundraising which will be used for the Company's inaugural royalty investments and working capital, in anticipation of delivering its maiden dividend to shareholders.

· The Company is pleased to have several significant institutional shareholders holding over 3 per cent. of the Company, including Hargreaves Hale, Brookfield's Partner Value Investments Inc., AXA Investment Managers, Artemis Investment Management, and Henderson Global Investors.

· The number of ordinary shares in issue immediately after Re-admission is 45,377,459, giving the Company a market capitalisation of approximately £21.6 million as at market close.

Commenting on the re-admission to AIM and the Fundraising, Neil Johnson, Chief Executive Officer, said:

"Duke Royalty is the first quoted diversified royalty company in Europe, and we look forward to bringing our alternative financing solutions to the European marketplace to help fill the funding gap for well-run, profitable, private companies across Europe and abroad.

"The Board has been delighted by the support of its new investors which are some of the largest investment managers in the world. The quality of our investors and exclusive global collaboration partner Oliver Wyman validates our belief in the exciting opportunity to bring royalty financing to European companies and UK investors. We look forward to delivering value for our shareholders in the months and years ahead."

 

Other than where defined, capitalised terms used in the announcement have the meanings given to them in the Fundraising announcement of 17 March 2017.

 

For further information, please contact:

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon-Brookes

+44 (0) 1481 741 240

Grant Thornton UK LLP (Nominated Adviser)

Colin Aaronson / Samantha Harrison / Jamie Barklem/ Carolyn Sansom

+44 (0) 20 7383 5100

Cantor Fitzgerald Europe (Joint Broker)

Marc Milmo / Catherine Leftley / Callum Butterfield

+44 (0) 207 894 7000

Mirabaud Securities LLP (Joint Broker)

Peter Krens / Edward Haig-Thomas

+44 (0) 20 3167 7222

 

About Duke Royalty

Headquartered in Guernsey, Duke Royalty Limited provides alternative financing solutions to a diversified range of businesses in Europe and abroad. Duke Royalty's experienced team and exclusive partnership provide financing solutions to private companies that are in need of capital but whose owners wish to maintain equity control of their business. Duke Royalty's royalty investments are intended to provide robust, stable, long term returns to its shareholders.

Duke Royalty is quoted on AIM, a market operated by the London Stock Exchange, under the ticker DUKE. For more information, visit dukeroyalty.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AIMPGURCWUPMGQW
Date   Source Headline
30th Aug 20223:07 pmRNSHolding(s) in Company
5th Aug 20227:00 amRNSNotice of Results and Presentations
4th Aug 20227:00 amRNSTrading Update
21st Jun 20227:00 amRNSInterim Dividend and Dividend Declaration
1st Jun 20224:25 pmRNSHolding(s) in Company
27th May 20229:08 amRNSDirector / PCA Dealings
26th May 20223:23 pmRNSResult of General Meeting and Issue of Equity
11th May 20227:05 amRNSRaises £20m through Placing and PrimaryBid Offer
10th May 20225:08 pmRNSPrimaryBid Offer
10th May 20224:44 pmRNSPlacing to raise a minimum of £15 million
28th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
20th Apr 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
11th Apr 20227:00 amRNSTrading Update
18th Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Mar 20227:00 amRNSIncreased Interim Dividend & Dividend Declaration
2nd Mar 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
25th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
17th Feb 20227:00 amRNSFurther re: Directorate Change
14th Feb 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
2nd Feb 20227:00 amRNSDirectorate Changes
1st Feb 202210:02 amRNSReplacement - Trading Update
1st Feb 20227:00 amRNSTrading Update
20th Jan 20227:00 amRNSFollow-On Investment into Existing Royalty Partner
23rd Dec 20212:30 pmRNSHolding(s) in Company
23rd Dec 20217:01 amRNSTrading Update
23rd Dec 20217:00 amRNSFollow-on investment into existing Royalty Partner
22nd Dec 20213:52 pmRNSFollow-on investment into existing Royalty Partner
16th Dec 20217:00 amRNSNew Royalty Agreement
14th Dec 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
7th Dec 20217:00 amRNSEnters into Largest Royalty Agreement To Date
3rd Dec 20217:00 amRNSInterim Results
2nd Dec 20217:00 amRNSCompletion of £4.2 million Follow-On Investment
25th Nov 20217:00 amRNSNotice of Interim Results
29th Oct 20214:03 pmRNSLong Term Incentive Plan Awards
27th Oct 20217:01 amRNSFollow-On Investment into Existing Royalty Partner
27th Oct 20217:00 amRNSHolding(s) in Company
22nd Oct 20214:36 pmRNSResult of Annual General Meeting
16th Sep 20217:01 amRNSInterim Dividend and Dividend Declaration
16th Sep 20217:00 amRNSFinal Results
7th Sep 20217:00 amRNS£2.2m Follow-On Investment into Royalty Partner
2nd Sep 20217:00 amRNSHolding(s) in Company
17th Aug 20217:00 amRNSInvestor Presentation
11th Aug 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20217:00 amRNSNotice of Results and Analyst Presentation
2nd Aug 20217:00 amRNSNew Royalty Agreement
26th Jul 20217:00 amRNSTrading Update
22nd Jul 20217:00 amRNSNew Royalty Agreement
1st Jul 20217:00 amRNSNew Royalty Agreement with Fairmed Healthcare AG
17th Jun 20217:00 amRNSInterim Dividend and Dividend Declaration
10th May 20217:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.